ID: ALA3350760

Max Phase: Preclinical

Molecular Formula: C13H13N3O2

Molecular Weight: 243.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(/C=N/Nc2ccccn2)c1O

Standard InChI:  InChI=1S/C13H13N3O2/c1-18-11-6-4-5-10(13(11)17)9-15-16-12-7-2-3-8-14-12/h2-9,17H,1H3,(H,14,16)/b15-9+

Standard InChI Key:  FFZWBZJRENXDNU-OQLLNIDSSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.27Molecular Weight (Monoisotopic): 243.1008AlogP: 2.24#Rotatable Bonds: 4
Polar Surface Area: 66.74Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.27CX Basic pKa: 4.62CX LogP: 2.72CX LogD: 2.71
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: -1.32

References

1. Unpublished dataset,